Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

Patrick Collier, Chris J Watson, Victor Voon, Dermot Phelan, Aftab Jan, George Mak, Ramon Martos, John A Baugh, Mark T Ledwidge, Kenneth M McDonald

Research output: Contribution to journalArticlepeer-review

130 Citations (Scopus)

Abstract

AIMS: Hypertension is one of the main drivers of the heart failure (HF) epidemic. The aims of this study were to profile fibro-inflammatory biomarkers across stages of the hypertensive heart disease (HHD) spectrum and to examine whether particular biochemical profiles in asymptomatic patients identify a higher risk of evolution to HF.

METHODS AND RESULTS: This was a cross-sectional observational study involving a population of 275 stable hypertensive patients divided into two different cohorts: Group 1, asymptomatic hypertension (AH) (n= 94); Group 2, HF with preserved ejection fraction (n= 181). Asymptomatic hypertension patients were further subdivided according to left atrial volume index ≥34 mL/m(2) (n= 30) and <34 mL/m(2) (n= 64). Study assays involved inflammatory markers [interleukin 6 (IL6), interleukin 8 (IL8), monocyte chemoattractant protein 1 (MCP1), and tumour necrosis factor α], collagen 1 and 3 metabolic markers [carboxy-terminal propeptide of collagen 1, amino-terminal propeptide of collagen 1, amino-terminal propeptide of collagen 3 (PIIINP), and carboxy-terminal telopeptide of collagen 1 (CITP)], extra-cellular matrix turnover markers [matrix metalloproteinase 2 (MMP2), matrix metalloproteinase 9 (MMP9), and tissue inhibitor of metalloproteinase 1 (TIMP1)], and the brain natriuretic peptide. Data were adjusted for age, sex, systolic blood pressure, and creatinine. Heart failure with preserved ejection fraction was associated with an increased inflammatory signal (IL6, IL8, and MCP1), an increased fibrotic signal (PIIINP and CITP), and an increased matrix turnover signal (MMP2 and MMP9). Alterations in MMP and TIMP enzymes were found to be significant indicators of greater degrees of asymptomatic left ventricular diastolic dysfunction.

CONCLUSION: These data define varying fibro-inflammatory profiles throughout different stages of HHD. In particular, the observations on MMP9 and TIMP1 raise the possibility of earlier detection of those at risk of evolution to HF which may help focus effective preventative strategies.

Original languageEnglish
Pages (from-to)1087-95
Number of pages9
JournalEuropean Journal of Heart Failure
Volume13
Issue number10
DOIs
Publication statusPublished - Oct 2011

Keywords

  • Aged
  • Biomarkers
  • Chemokine CCL2
  • Cross-Sectional Studies
  • Diastole
  • Echocardiography, Doppler
  • Female
  • Heart Atria
  • Heart Failure
  • Humans
  • Hypertension
  • Interleukin-6
  • Interleukin-8
  • Male
  • Matrix Metalloproteinase 9
  • Tissue Inhibitor of Metalloproteinase-1
  • Ventricular Dysfunction, Left
  • Ventricular Remodeling

Fingerprint

Dive into the research topics of 'Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?'. Together they form a unique fingerprint.

Cite this